However, a study published last year reveals the convection-enhanced delivery of the oncolytic adenovirus Delta24-RGD to 20 patients with recurrent GBM provides a safe treatment in this phase 1 trial, with increased numbers of macrophages and CD4+ and CD8+ T cells found in the tumor specimens [109]. Here, CD8A is linked to neoplasm.